Medicare Enrolled
Dr. Andrew Sulich, MD
Rheumatology · Saint Clair Shores, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sulich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sulich?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sulich
Dr. Andrew Sulich is a rheumatology specialist in Saint Clair Shores, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sulich performed 214,158 Medicare services across 1,308 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sulich received a total of $1,848,997 from 59 pharmaceutical and/or device companies across 3796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sulich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in MI
$1,848,997 industry payments
Medicare Practice Summary
Medicare Utilization ↗214,158
Medicare services
Top 1% in MI for rheumatology
1,308
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,271 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 122,200 | $5 | $7 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
54,800 | $4 | $10 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
16,850 | $10 | $30 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
12,250 | $33 | $61 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
629 | $96 | $175 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
608 | $106 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $58 | $135 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
247 | $59 | $150 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
176 | $25 | $65 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
165 | $6 | $100 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
141 | $1 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
117 | $122 | $250 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
100 | $23 | $55 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
93 | $53 | $186 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $122 | $235 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
28 | $28 | $65 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
28 | $23 | $55 |
| New patient office visit, complex (60-74 min) | 22 | $156 | $300 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
21 | $9 | $22 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $6 | $15 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
12 | $42 | $125 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.9% high complexity
85.5% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,848,997
Total received (2018-2024)
Avg $264,142/year across 7 years
Top 2% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
3,796
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,777,888 (96.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$60,138 (3.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,971 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$253,081
2023
$231,453
2022
$198,242
2021
$227,294
2020
$141,290
2019
$407,012
2018
$390,625
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$129,864
UCB, Inc.
$42,095
ABBVIE INC.
$27,772
Amgen Inc.
$13,897
ANI Pharmaceuticals, Inc.
$12,907
GENZYME CORPORATION
$10,084
GlaxoSmithKline, LLC.
$7,200
Novartis Pharmaceuticals Corporation
$6,388
Janssen Biotech, Inc.
$962
Pacira Pharmaceuticals Incorporated
$307
Sandoz Inc.
$284
E.R. Squibb & Sons, L.L.C.
$254
Lilly USA, LLC
$235
PFIZER INC.
$190
SOBI, INC
$178
Organon Llc
$137
Aurinia Pharma U.S., Inc.
$75
Fresenius Kabi USA, LLC
$75
Genentech USA, Inc.
$52
Janssen Scientific Affairs, LLC
$30
Kiniksa Pharmaceuticals International, plc
$23
Zimmer Biomet Holdings, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Ferring Pharmaceuticals Inc.
$14
Top 3 companies account for 78.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$307,929
Celgene Corporation
$263,491
Lilly USA, LLC
$240,769
Amgen Inc.
$181,739
UCB, Inc.
$169,529
Novartis Pharmaceuticals Corporation
$155,223
GlaxoSmithKline, LLC.
$101,778
Genentech USA, Inc.
$88,189
Regeneron Healthcare Solutions, Inc.
$63,829
ABBVIE INC.
$52,050
GENZYME CORPORATION
$50,594
AbbVie Inc.
$45,421
Aurinia Pharma U.S., Inc.
$35,046
ANI Pharmaceuticals, Inc.
$27,460
Janssen Biotech, Inc.
$16,541
AbbVie, Inc.
$15,898
NOVARTIS PHARMACEUTICALS CORPORATION
$9,322
SOBI, INC
$6,134
Exeltis, USA Inc.
$5,988
PFIZER INC.
$3,103
E.R. Squibb & Sons, L.L.C.
$2,460
Sobi, Inc
$1,747
Horizon Therapeutics plc
$1,019
Pacira Pharmaceuticals Incorporated
$823
Sandoz Inc.
$301
Mallinckrodt Hospital Products Inc.
$225
Janssen Scientific Affairs, LLC
$204
MEDAC PHARMA, INC.
$202
Cardinal Health 110 LLC
$200
Flexion Therapeutics, Inc.
$170
Organon Llc
$137
Fresenius Kabi USA, LLC
$136
Organon LLC
$105
Amneal Pharmaceuticals LLC
$100
Takeda Pharmaceuticals U.S.A., Inc.
$96
Actelion Pharmaceuticals US, Inc.
$95
Alexion Pharmaceuticals, Inc.
$94
Hikma Pharmaceuticals USA
$92
SANOFI-AVENTIS U.S. LLC
$91
Antares Pharma, Inc.
$89
Alvogen Inc
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$51
Merck Sharp & Dohme Corporation
$51
Mallinckrodt Enterprises LLC
$50
Ferring Pharmaceuticals Inc.
$48
Ironwood Pharmaceuticals, Inc
$44
Mylan Institutional Inc.
$41
Arcutis Biotherapeutics, Inc.
$29
Mission Pharmacal Company
$25
Kiniksa Pharmaceuticals International, plc
$23
Kiniksa Pharmaceuticals, Ltd.
$21
Zimmer Biomet Holdings, Inc.
$21
Genentech, Inc.
$20
Mallinckrodt LLC
$19
Celltrion USA Inc.
$18
Horizon Pharma plc
$15
Bioventus LLC
$13
Sebela Pharmaceuticals Inc.
$11
West-Ward Pharmaceuticals
$11
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUEXIS · DUZALLO · EUFLEXXA · EVENITY · EVUSHELD · EXPAREL · Enbrel · Exparel · FLUMIST QUADRIVALENT · FORTEO · GAMIFANT · GELSYN 3 · Gel-One Cross-linked Hyaluronate · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · IDACIO · ILARIS · INFLECTRA · Iovera · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · OTREXUP · Otezla · Otrexup · PAXLOVID · PENNSAID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · Synagis · TALTZ · TAVNEOS · TEPEZZA · TERIPARATIDE · TREMFYA · Tavneos · UPLIZNA · Uloric · Ultomiris · VIMOVO · XELJANZ · YUFLYMA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for rheumatology in MI.
Geographic Context
Rheumatologists within 10 mi
56
Per 100K population
6.4
County median income
$76,399
Nearest hospital
HENRY FORD HEALTH ST JOHN HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sulich is a mixed practice specialist, with above-average Medicare volume (top 1% in MI), with speaking/promotional industry engagement in the top 2% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sulich experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Sulich performed 122,200 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sulich receive payments from pharmaceutical companies?
Yes. Dr. Sulich received a total of $1,848,997 from 59 companies across 3,796 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sulich's costs compare to other rheumatologists in Saint Clair Shores?
Dr. Sulich's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sulich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Saint Clair Shores
Browse rheumatologists in Saint Clair Shores ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MI
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MI
Which MI rheumatologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology